CLAIM #3324 · Abbott Laboratories (ABT) · 2025Q4 earnings call · Jan 22, 2026 · due Dec 31, 2026
“And we forecast our adjusted tax rate to be in the range of 15 to 16%.”
Philip Boudreau · CFO
How to check this claim
Look at: Full-year adjusted effective tax rate
It came true if: Adjusted tax rate between 15.0% and 16.0%
Where: Company-reported full-year adjusted results (earnings release / 10-K non-GAAP reconciliation)
In context
“ncreased 20 basis points compared to the prior year. Adjusted R&D was 6.2% of sales and adjusted SG&A was 25.1% of sales. Adjusted operating margin was 25.8% of sales, which reflects an increase of 150 basis points compared to the prior year. Turning to our outlook for 2026, today, we issued guidance for full-year adjusted earnings per share of $5.55 to $5.80. This reflects 10% growth at the midpoint of the range and contemplates an adjusted earnings per share forecast of $1.12 to $1.18 for the first quarter. For the year, we forecast organic sales growth to be in the range of 6.5% to 7.5%. Based on current rates, we expect exchange to have a favorable impact of around 1% on full-year reported sales, which includes an expected favorable impact of around 3% on first-quarter reported sales. And we forecast our adjusted tax rate to be in the range of 15 to 16%. With that, we'll now open the call for questions. Operator: Thank you. At this time, we will conduct the question and answer session. As a reminder, to ask a question, you will need to press 11 on your telephone. You will then hear an automated advising you that your hand is raised. To withdraw your question, please press 11 again. For optimal sound quality, we kindly ask that you please use your handset instead of your speakerphone when asking your question. Our first question will come from Larry Biegelsen from Wells Fargo. Your line is open. Larry Biegelsen: Good morning. Thanks for taking the question. So, Robert, on the last call, you seemed comfortable with consensus revenue growth, but you're guiding a little bit lower today. I assume that's related to nutrition. Can you talk about”
Verify independently
SEC filings for ABT ↗ · Claim quote is verbatim from the 2025Q4 earnings call.